GOLDMAN SACHS GROUP INC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 129 filers reported holding ANIKA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,537,050
-1.9%
82,504
+36.8%
0.00%
Q2 2023$1,566,360
+8.8%
60,291
+20.3%
0.00%
Q1 2023$1,439,045
+4.8%
50,106
+8.0%
0.00%
Q4 2022$1,373,292
-15.2%
46,395
-31.8%
0.00%
Q3 2022$1,619,000
-50.9%
68,028
-53.9%
0.00%
-100.0%
Q2 2022$3,297,000
+30.1%
147,697
+46.4%
0.00%0.0%
Q1 2022$2,534,000
+549.7%
100,917
+826.9%
0.00%
Q4 2021$390,000
-69.7%
10,888
-64.0%
0.00%
Q3 2021$1,286,000
-37.8%
30,213
-36.8%
0.00%
Q2 2021$2,069,000
+12.1%
47,790
+5.6%
0.00%
Q1 2021$1,846,000
-40.0%
45,267
-33.4%
0.00%
-100.0%
Q4 2020$3,077,000
-13.6%
67,987
-32.4%
0.00%0.0%
Q3 2020$3,561,000
-24.0%
100,630
-19.0%
0.00%0.0%
Q2 2020$4,688,000
-27.5%
124,257
-44.4%
0.00%
-50.0%
Q1 2020$6,464,000
-59.8%
223,574
-27.9%
0.00%
-50.0%
Q4 2019$16,067,000
+71.0%
309,876
+81.0%
0.00%
+33.3%
Q3 2019$9,397,000
+1.5%
171,181
-24.9%
0.00%0.0%
Q2 2019$9,261,000
+295.9%
227,999
+194.7%
0.00%
+200.0%
Q1 2019$2,339,000
-9.4%
77,358
+0.7%
0.00%0.0%
Q4 2018$2,581,000
-29.3%
76,789
-11.3%
0.00%0.0%
Q3 2018$3,652,000
-9.6%
86,571
-31.5%
0.00%0.0%
Q2 2018$4,041,000
-45.3%
126,292
-15.1%
0.00%
-50.0%
Q1 2018$7,394,000
-9.0%
148,714
-1.3%
0.00%0.0%
Q4 2017$8,122,000
-12.0%
150,643
-5.3%
0.00%0.0%
Q3 2017$9,227,000
+499.9%
159,087
+410.4%
0.00%
Q2 2017$1,538,000
-0.5%
31,172
-12.4%
0.00%
Q1 2017$1,545,000
-29.0%
35,574
-19.9%
0.00%
-100.0%
Q4 2016$2,175,000
-29.5%
44,425
-31.1%
0.00%0.0%
Q3 2016$3,085,000
+756.9%
64,464
+861.9%
0.00%
Q2 2016$360,000
-18.7%
6,702
-32.3%
0.00%
Q1 2016$443,000
-33.4%
9,903
-43.2%
0.00%
Q4 2015$665,000
+1.4%
17,420
-15.4%
0.00%
Q3 2015$656,000
-5.7%
20,598
+21.8%
0.00%
Q1 2015$696,000
-43.8%
16,910
-44.4%
0.00%
Q4 2014$1,239,000
-29.3%
30,423
-36.3%
0.00%
-100.0%
Q3 2014$1,752,000
-5.8%
47,790
+19.1%
0.00%0.0%
Q2 2014$1,859,000
+46.0%
40,128
+29.5%
0.00%
Q1 2014$1,273,000
+37.9%
30,975
+28.1%
0.00%
Q4 2013$923,000
+321.5%
24,187
+164.2%
0.00%
Q3 2013$219,0009,1550.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders